[Hemolytic uremic syndrome. Treatment of secondary glomerulopathy].
Chronic renal failure (CRF) is the most severe complication of hemolytic uremic syndrome (HUS). In 1996, the histological sequence of changes in patients with long lasting oligoanuric periods was clarified. In the last years different therapeutic schemes have been proposed in order to slacken the development of terminal CRF in different renal conditions secondary to diabetes and other diseases. Some of these cases can suffer the onset of renal failure at adolescence. In this review, response to two treatment schemes in different patients with HUS and proteinuria with or without hypertension or renal failure is commented. Early indication of poor sodium diet and strict control of protein intake at the very moment of hospital discharge is strongly recommended, as well as angiotensin II conversion inhibiting enzymes (iACE) at the appearance of proteinuria.
Caletti
María G
MG
Servicio de Nefrología y de Anatomía Patológica, Hospital de Pediatría Prof. Dr. Juan P. Garrahan. mcaletti@garrahan.gov.ar
Gallo
Guillermo
G
D000293:Adolescent; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001706:Biopsy; D002648:Child; D004039:Diet, Sodium-Restricted; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate / Q000502:physiology; D005923:Glomerulosclerosis, Focal Segmental / Q000503:physiopathology; D006463:Hemolytic-Uremic Syndrome / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D011379:Prognosis; D011507:Proteinuria / Q000503:physiopathology
D000806:Angiotensin-Converting Enzyme Inhibitors